[1]刘界宇,李泗云,黄继华,等.基于网络药理学和分子对接技术分析高良姜治疗慢性萎缩性胃炎的作用机制[J].医学信息,2024,37(18):31-36.[doi:10.3969/j.issn.1006-1959.2024.18.006]
　LIU Jie-yu,LI Si-yun,HUANG Ji-hua,et al.Mechanism of Lesser Galangal Rhizome in the Treatment of Chronic Atrophic Gastritis Based on Network Pharmacology and Molecular Docking Technology[J].Journal of Medical Information,2024,37(18):31-36.[doi:10.3969/j.issn.1006-1959.2024.18.006]
点击复制

基于网络药理学和分子对接技术分析高良姜治疗慢性萎缩性胃炎的作用机制()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年18期
页码:
31-36
栏目:
中医药信息学
出版日期:
2024-09-15

文章信息/Info

Title:
Mechanism of Lesser Galangal Rhizome in the Treatment of Chronic Atrophic Gastritis Based on Network Pharmacology and Molecular Docking Technology
文章编号:
1006-1959（2024）18-0031-06
作者:
刘界宇1; 2; 李泗云1; 2; 黄继华1; 2; 吉玉屏2; 刘中建3; 张 帆2
1.大理大学医学院，云南 大理 671000；2.云南省第三人民医院/大理大学第二附属医院消化内科，云南 昆明 650000；3.云南省第一人民医院基础和临床医学研究所，云南 昆明 650034
Author(s):
LIU Jie-yu1; 2; LI Si-yun1; 2; HUANG Ji-hua1; 2; JI Yu-ping2; LIU Zhong-jian3; ZHANG Fan2
1.Medical School,Dali University,Dali 671000,Yunnan,China;2.Department of Digestive Medicine,the Third People’s Hospital of Yunnan Province/Dali University Second Affiliated Hospital,Kunming 650000,Yunnan,China;3.Institute of Basic and Clinical Medicine,the First People’s Hospital of Yunnan Province,Kunming 650034,Yunnan,China
关键词:
高良姜; 慢性萎缩性胃炎; 网络药理学; 分子对接
Keywords:
Lesser galangal rhizome; Chronic atrophic gastritis; Network pharmacology; Molecular docking
分类号:
R285
DOI:
10.3969/j.issn.1006-1959.2024.18.006
摘要:
目的 运用网络药理学和分子对接技术分析高良姜治疗慢性胃炎的作用机制。方法 通过中药系统药理学数据库（TCMSP）获取高良姜的活性成分，筛选出高良姜作用靶点，构建中药调控网络。通过收集数据库中的慢性萎缩性胃炎相关基因，进行基因合并绘制VENN图。将得到的药物相关靶点与疾病相关靶点进行映射筛选得到相关交集靶点，并构建PPI网络，对其进行GO和KEGG富集分析。最后利用Vina软件进行分子对接实验验证进行可视化分析。结果 通过网络药理学和分子对接技术获得高良姜活性成分13个，与慢性萎缩性胃炎的交集靶点85个，构建蛋白互作网络得出核心基因包括FOS、MYC、MAPK1等，核心药物成分主要包括槲皮素等。GO分析得出生物功能主要涉及对镉离子的反应等，KEGG分析得出高良姜治疗慢性萎缩性胃炎主要涉及到IL-17信号通路，TNF信号通路、Toll样受体信号通路等，以此调控胃黏膜细胞增殖与凋亡。进而发挥着治疗慢性萎缩性胃炎的效果，提高药物的治疗效果，降低毒副作用，为深入高良姜治疗慢性萎缩性胃炎的作用机制研究提供新思路。结论 高良姜通过多成分、多靶点、多通路治疗慢性萎缩性胃炎，但仍需进一步实验或临床验证。
Abstract:
Objective To analyze the mechanism of lesser galangal rhizome in the treatment of chronic gastritis by network pharmacology and molecular docking technology.Methods The active components of lesser galangal rhizome were obtained through the Traditional Chinese Medicine Systems Pharmacology Database (TCMSP), and the target of lesser galangal rhizome was screened out to construct the regulation network of traditional Chinese medicine. By collecting the genes related to chronic atrophic gastritis in the database, the VENN map was drawn by gene merging. The obtained drug-related targets and disease-related targets were mapped and screened to obtain relevant intersection targets, and a PPI network was constructed to perform GO and KEGG enrichment analysis. Finally, Vina software was used to verify the molecular docking experiment for visual analysis.Results Through network pharmacology and molecular docking technology, 13 active components of lesser galangal rhizome were obtained, and 85 targets were intersected with chronic atrophic gastritis. The protein interaction network was constructed to obtain the core genes including FOS, MYC, MAPK1, etc., and the core drug components mainly include quercetin. GO analysis showed that biological functions mainly involved the response to cadmium ions. KEGG analysis showed that the pathway of lesser galangal rhizome in treatment of chronic atrophic gastritis mainly involved IL-17 signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, etc., in order to regulate the proliferation and apoptosis of gastric mucosal cells. In turn, it played a role in the treatment of chronic atrophic gastritis, improved the therapeutic effect of drugs, reduced toxic and side effects, and provided new ideas for further research on the mechanism of lesser galangal rhizome in the treatment of chronic atrophic gastritis.Conclusion Lesser galangal rhizome through multi-component, multi-target and multi-pathway in treatment of chronic atrophic gastritis, but further experimental or clinical verification is still needed.

参考文献/References:

[1]陈少忠,郑伟伟.疏肝安胃汤治疗肝胃气滞型慢性萎缩性胃炎的临床观察[J].中国中医药科技,2020,27(2):233-235.[2]Pimentel-Nunes P,Libanio D,Marcos-Pinto R,et al.Management of epithelial precancerous conditions and lesions in the stomach(MAPS II):European Society of Gastrointestinal Endoscopy(ESGE),European Helicobacter and Microbiota Study Group(EHMSG),European Society of Pathology(ESP),and Sociedade Portuguesa de Endoscopia Digestiva(SPED) guideline update 2019[J].Endoscopy,2019,51(4):365-388.[3]中华中医药学会脾胃病分会,张声生,唐旭东.慢性胃炎中医诊疗专家共识意见(2017)[J].中华中医药杂志,2017,32(7):3060-3064.[4]中华医学会消化病学分会.中国慢性胃炎共识意见(2017年,上海)[J].中华消化杂志,2017,37(11):721-738.[5]Wu J,Hong S,Xie X,et al.A Network Pharmacology-Based Study on the Anti-Lung Cancer Effect of Dipsaci Radix[J].Evid Based Complement Alternat Med,2020,2020:7424061.[6]Liu Z,Guo F,Wang Y,et al.BATMAN-TCM:a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine[J].Sci Rep,2016,6:21146.[7]Ashburner M,Ball CA,Blake JA,et al.Gene ontology:tool for the unification of biology.The Gene Ontology Consortium[J].Nat Genet,2000,25(1):25-29.[8]杨印智,王继栓,王晓琴,等.中医辨证治疗慢性萎缩性胃炎疗效观察[J].现代中西医结合杂志,2015,(7):768-769.[9]李洪福,李永辉,王勇,等.高良姜化学成分及药理活性的研究[J].中国实验方剂学杂志,2014,20(7):236-244.[10]Modzelewska B,Drygalski K,Kleszczewski T,et al.Quercetin relaxes human gastric smooth muscles directly through ATP-sensitive potassium channels and not depending on the nitric oxide pathway[J].Neurogastroenterol Motil,2021,33(7):e14093.[11]Hu XT,Ding C,Zhou N,et al.Quercetin protects gastric epithelial cell from oxidative damage in vitro and in vivo[J].Eur J Pharmacol,2015,754:115-124.[12]Dang CV.MYC on the path to cancer[J].Cell,2012,149(1):22-35.[13]Schaub FX,Dhankani V,Berger AC,et al.Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas[J].Cell Syst,2018,6(3):282-300.e2.[14]Noi M,Mukaisho KI,Murakami S,et al.Expressions of ezrin,ERK,STAT3,and AKT in tongue cancer and association with tumor characteristics and patient survival[J].Clin Exp Dent Res,2020,6(4):420-427.[15]Wang K,Ji W,Yu Y,et al.Correction:FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition,and metastasis in FGFR1-amplified lung cancer[J].Oncogene,2020,39(42):6619-6620.[16]王佳慧,郑洋,王嘉孺,等.基于KEGG通路和基因网络对慢性萎缩性胃炎靶点基因的筛选[J].中国医药导报,2019,16(2):159-163,173.[17]中国中西医结合学会消化系统疾病专业委员会.慢性萎缩性胃炎中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2018,26(2):121-131.[18]成映霞,段永强,朱立鸣,等.益气健脾活血中药对萎缩性胃炎TNF-α、IL-2和EGF表达的影响[J].中国老年学杂志,2013,33(15):3649-3651.[19]Song X,Xin N,Wang W,et al.Wnt/β-catenin,an oncogenic pathway targeted by H.pylori in gastric carcinogenesis[J].Oncotarget,2015,6(34):35579-35588.[20]Ghoreschi K,Laurence A,O’Shea JJ.Janus kinases in immune cell signaling[J].Immunol Rev,2009,228(1):273-287.

相似文献/References:

[1]陶 剑,奚美娟,张 平.益胃活血方治疗血瘀型慢性萎缩性胃炎临床观察[J].医学信息,2018,31(11):11.[doi:10.3969/j.issn.1006-1959.2018.11.004]
　TAO Jian,XI Mei-juan,ZHANG Ping.Clinical Observation on Yiwei Huoxue Recipe in Treating Chronic Atrophic Gastritis of Blood Stasis Type[J].Journal of Medical Information,2018,31(18):11.[doi:10.3969/j.issn.1006-1959.2018.11.004]
[2]张红新.益气清热活血方治疗慢性萎缩性胃炎及其 癌前期病变的临床研究[J].医学信息,2018,31(13):151.[doi:10.3969/j.issn.1006-1959.2018.13.046]
　ZHANG Hong-xin.Clinical Study of Yiqi Qingre Huoxue Decoction in Treating Chronic Atrophic Gastritis and Its Precancerous Lesions[J].Journal of Medical Information,2018,31(18):151.[doi:10.3969/j.issn.1006-1959.2018.13.046]
[3]张 皓.慢性萎缩性胃炎并发缺铁性贫血的危险因素分析[J].医学信息,2019,32(07):112.[doi:10.3969/j.issn.1006-1959.2019.07.033]
　ZHANG Hao.Logistic Regression Analysis of Risk Factors for Chronic Atrophic Gastritis Complicated with Iron Deficiency Anemia[J].Journal of Medical Information,2019,32(18):112.[doi:10.3969/j.issn.1006-1959.2019.07.033]
[4]梁丽丽,张 庆,戴 明.慢性萎缩性胃炎中医病机探讨[J].医学信息,2020,33(01):154.[doi:10.3969/j.issn.1006-1959.2020.01.050]
[5]陈 璐.温阳健脾汤治疗慢性萎缩性胃炎癌前病变的疗效及安全性[J].医学信息,2021,34(01):167.[doi:10.3969/j.issn.1006-1959.2021.01.046]
　CHEN Lu.Efficacy and Safety of Wenyang Jianpi Soup in the Treatment of CAG-PLGC[J].Journal of Medical Information,2021,34(18):167.[doi:10.3969/j.issn.1006-1959.2021.01.046]
[6]吴春凤,黄伟荣.黄伟荣从“虚”“瘀”论治慢性萎缩性胃炎[J].医学信息,2021,34(02):165.[doi:10.3969/j.issn.1006-1959.2021.02.046]
[7]吕学富.石斛养胃汤联合胶体果胶铋干混悬剂及阿莫西林治疗慢性萎缩性胃炎的临床疗效观察[J].医学信息,2021,34(24):163.[doi:10.3969/j.issn.1006-1959.2021.24.043]
　LYU Xue-fu.Clinical Efficacy of Shihu Yangwei Decoction Combined with Colloidal Bismuth Pectin for Suspension and Amoxicillin in the Treatment of Chronic Atrophic Gastritis[J].Journal of Medical Information,2021,34(18):163.[doi:10.3969/j.issn.1006-1959.2021.24.043]
[8]李虹霞,刘伏山.慢性萎缩性胃炎的中西医治疗[J].医学信息,2022,35(11):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
　LI Hong-Xia,LIU Fu-shan.Treatment of Chronic Atrophic Gastritis with Traditional Chinese and Western Medicine[J].Journal of Medical Information,2022,35(18):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
[9]熊 鹰.中医疗法在慢性萎缩性胃炎治疗中的研究现状[J].医学信息,2023,36(23):189.[doi:10.3969/j.issn.1006-1959.2023.23.047]
　XIONG Ying.Research Status of Traditional Chinese Medicine Therapy for Chronic Atrophic Gastritis[J].Journal of Medical Information,2023,36(18):189.[doi:10.3969/j.issn.1006-1959.2023.23.047]
[10]汪尚勇,姜立飞.双歧杆菌乳杆菌三联活菌联合改良序贯疗法治疗Hp阳性慢性萎缩性胃炎的疗效与安全性[J].医学信息,2023,36(24):69.[doi:10.3969/j.issn.1006-1959.2023.24.013]
　WANG Shang-yong,JIANG Li-fei.Efficacy and Safety of Live Combined Bifidobacterium and Lactobacillus Combined with Modified Sequential Therapy in the Treatment of Hp Positive Chronic Atrophic Gastritis[J].Journal of Medical Information,2023,36(18):69.[doi:10.3969/j.issn.1006-1959.2023.24.013]

更新日期/Last Update: 1900-01-01